We started LeoApexBond because the research peptide market had a pattern we could not stomach: vague purity claims, locked-away Certificates of Analysis, and a wall of stock photography standing in for evidence. Labs that did the work were hiding it, and labs that did not were selling the appearance of it.
So the company was built the other way around. Every batch is synthesized under cGMP-aligned protocols, lyophilized at the source facility, and independently assayed at an ISO/IEC 17025-accredited partner lab. We do not publish a purity number we cannot hand a lab report for, and we do not give the buyer any reason to trust us without one.
We publish every COA on a public verification page so the people buying the compound — not just us — decide whether the assay stands up. If a batch comes back below the purity we promised, it does not ship. If a customer needs a method, a chromatogram, or the name of the lab that ran the assay, we hand it over the same day.
None of this is special the way marketing pages usually mean "special". It is the floor. What we are actually trying to build is a lab people recommend in plain English because the receipts are there when someone asks to see them.
The work is the only moat we have. So we do the work, and then we show it.
— The LeoApexBond lab team · leoapexbond@polsia.app